Total planned funding: $167,082,044
Allocations
Countries/Regions
Ukraine | $167,082,044 |
Organizational Types
Unknown | $48,478,220 |
NGO | $41,361,065 |
Private Contractor | $30,489,191 |
Own Agency | $19,453,033 |
Multi-lateral Agency | $11,775,607 |
University | $8,016,234 |
Implementing Agency | $4,172,000 |
Other USG Agency | $3,086,694 |
Host Country Government Agency | $250,000 |
Program Areas
Governance and Systems | $69,707,007 |
Treatment | $27,769,208 |
Testing | $25,669,626 |
Prevention | $19,185,942 |
Management and Operations | $13,109,629 |
Care | $11,227,932 |
Budget Codes
OHSS: Health Systems Strengthening | $37,383,078 |
HVCT: Testing: HIV Testing and Counseling | $25,669,626 |
HVSI: Strategic Information | $20,040,835 |
HTXS: Treatment: Adult Treatment | $16,338,094 |
HVMS: Management and Operations | $13,109,629 |
HLAB: Laboratory Infrastructure | $12,283,094 |
HTXD: Treatment: ARV Drugs | $11,431,114 |
HVOP: Sexual Prevention: Other Sexual Prevention | $8,822,242 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $8,212,092 |
HVTB: Care: TB/HIV | $6,867,388 |
HKID: Care: Orphans and Vulnerable Children | $2,485,509 |
HBHC: Care: Adult Care and Support | $1,875,035 |
HMBL: Biomedical Prevention: Blood Safety | $1,333,557 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $274,694 |
HMIN: Biomedical Prevention: Injection Safety | $250,000 |
Top Partner Programs
Not Available:
$37,028,077
Countries/Regions
Chemonics International:
$16,719,470
Countries/Regions
USG Aggregated Agencies:
$15,664,383
Countries/Regions
Deloitte Consulting Limited:
$10,671,511
Countries/Regions